Evaluation of 18F-FDG uptake for detecting lymph node metastasis of esophagus cancer

Evaluation of 18F-FDG uptake for detecting lymph node metastasis of esophagus cancer - Evaluation of 18F-FDG uptake for detecting lymph node metastasis of esophagus cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017562

Enrollment

Registered

2015-05-14

Start date

2014-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Squamous cell carcinoma of esophagus confirmed by pathological examination (2) Enable to proceed curative operation (3) normal heart, renal,and liver function (4) European clinical oncology group performance status (ECOG PS) 0 or 1 (5)Enable to examine PET-CT

Exclusion criteria

Exclusion criteria: (1) severe drug allergy (2) diabetes mellitus (3) any severe ongoing comorbidity (4) prior malignant diseases (5) synchronous malignant diseases other than gastric cancer (6) contraindication of FDG PET including pregnancy

Design outcomes

Primary

Measure	Time frame
Relationship between 18F-FDG uptake and lymph node involvement	—

Countries

Japan

Contacts

Public ContactYasuyuki Seto

University of Tokyo Hospital Department of Gastrointestinal Surgery

seto-tky@umin.ac.jp+81-3-3815-5411

Outcome results